GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Accumulated other comprehensive income (loss)

NewAmsterdam Pharma Co NV (FRA:KH6) Accumulated other comprehensive income (loss) : €4.10 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. NewAmsterdam Pharma Co NV's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was €4.10 Mil.

NewAmsterdam Pharma Co NV's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2024 (€3.98 Mil) to Dec. 2024 (€4.27 Mil) but then declined from Dec. 2024 (€4.27 Mil) to Mar. 2025 (€4.10 Mil).

NewAmsterdam Pharma Co NV's annual Accumulated other comprehensive income (loss) declined from Dec. 2022 (€4.17 Mil) to Dec. 2023 (€4.06 Mil) but then increased from Dec. 2023 (€4.06 Mil) to Dec. 2024 (€4.27 Mil).

NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss) Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss) Chart

NewAmsterdam Pharma Co NV Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
- 0.59 4.17 4.06 4.27

NewAmsterdam Pharma Co NV Quarterly Data
Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.07 4.11 3.98 4.27 4.10

NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

NewAmsterdam Pharma Co NV Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
HRMY LGND DNLI CGON KYMR FOLD VCEL ARWR TARS MIRM VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
NAMS:USA KH6:Germany
Address
Gooimeer 2-35, Naarden, NH, NLD, 1411 DC
Website
https://www.newamsterdampharma.com
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

NewAmsterdam Pharma Co NV Headlines

No Headlines